Get Details: These 3 Stocks are the Dark Horses of the Stock Market
Here is the latest financial fact sheet of Lupin. For more details, see the Lupin quarterly results and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.8 |
No. of shares | m | 452.65 |
% ch week | % | 6.1 |
% ch 1-mth | % | 15.2 |
% ch 12-mth | % | 44.0 |
52 week H/L | Rs | 1,121.9/505.0 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
LUPIN EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,127 | 1,750 | 1,465 | 986 | 882 | |
Low | Rs | 1,294 | 1,384 | 727 | 720 | 505 | |
Sales per share (Unadj.) | Rs | 316.4 | 387.4 | 349.6 | 324.1 | 339.4 | |
Earnings per share (Unadj.) | Rs | 50.2 | 56.6 | 5.6 | 13.4 | -5.9 | |
Diluted earnings per share | Rs | 49.9 | 56.5 | 5.6 | 13.4 | -6.0 | |
Cash flow per share (Unadj.) | Rs | 61.0 | 76.8 | 29.6 | 32.1 | 15.5 | |
Dividends per share (Unadj.) | Rs | 7.50 | 7.50 | 5.00 | 5.00 | 6.00 | |
Adj. dividends per share | Rs | 7.47 | 7.48 | 4.99 | 5.00 | 6.00 | |
Dividend yield (eoy) | % | 0.4 | 0.5 | 0.5 | 0.6 | 0.9 | |
Book value per share (Unadj.) | Rs | 247.8 | 298.9 | 300.3 | 303.7 | 276.7 | |
Adj. book value per share | Rs | 246.6 | 298.2 | 299.9 | 303.6 | 277.0 | |
Shares outstanding (eoy) | m | 450.58 | 451.58 | 452.08 | 452.49 | 453.00 | |
Bonus/Rights/Conversions | - | ESOP | ESOP | ESOP | ESOP | ||
Price / Sales ratio | x | 5.4 | 4.0 | 3.1 | 2.6 | 2.0 | |
Avg P/E ratio | x | 34.1 | 27.7 | 197.2 | 63.6 | -116.6 | |
P/CF ratio (eoy) | x | 28.0 | 20.4 | 37.1 | 26.6 | 44.8 | |
Price / Book Value ratio | x | 6.9 | 5.2 | 3.6 | 2.8 | 2.5 | |
Dividend payout | % | 14.9 | 13.2 | 90.0 | 37.3 | -100.9 | |
Avg Mkt Cap | Rs m | 770,740 | 707,513 | 495,502 | 386,064 | 314,201 | |
No. of employees | `000 | 16.4 | 16.8 | 17.0 | 17.7 | 18.3 | |
Total wages/salary | Rs m | 21,416 | 28,495 | 28,647 | 27,702 | 29,868 | |
Avg. sales/employee | Rs Th | 8,718.5 | 10,418.3 | 9,273.6 | 8,292.6 | 8,400.6 | |
Avg. wages/employee | Rs Th | 1,309.8 | 1,697.0 | 1,681.0 | 1,566.5 | 1,632.0 | |
Avg. net profit/employee | Rs Th | 1,382.6 | 1,523.0 | 147.4 | 343.0 | -147.2 |
LUPIN INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 142,555 | 174,943 | 158,042 | 146,646 | 153,748 | |
Other income | Rs m | 1,852 | 1,065 | 1,504 | 3,330 | 4,838 | |
Total revenues | Rs m | 144,407 | 176,008 | 159,545 | 149,976 | 158,585 | |
Gross profit | Rs m | 36,854 | 44,931 | 31,475 | 26,552 | 24,849 | |
Depreciation | Rs m | 4,871 | 9,122 | 10,859 | 8,461 | 9,702 | |
Interest | Rs m | 595 | 1,525 | 2,044 | 3,025 | 3,630 | |
Profit before tax | Rs m | 33,239 | 35,349 | 20,076 | 18,397 | 16,355 | |
Minority Interest | Rs m | -88 | -72 | -71 | -89 | 4 | |
Prior Period Items | Rs m | 49 | 83 | 35 | 38 | 39 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | -14,644 | -3,400 | -7,521 | |
Tax | Rs m | 10,593 | 9,785 | 2,885 | 8,879 | 11,571 | |
Profit after tax | Rs m | 22,607 | 25,575 | 2,513 | 6,066 | -2,694 | |
Gross profit margin | % | 25.9 | 25.7 | 19.9 | 18.1 | 16.2 | |
Effective tax rate | % | 31.9 | 27.7 | 14.4 | 48.3 | 70.8 | |
Net profit margin | % | 15.9 | 14.6 | 1.6 | 4.1 | -1.8 |
LUPIN BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 98,874 | 119,529 | 122,095 | 138,536 | 154,132 | |
Current liabilities | Rs m | 50,612 | 61,206 | 50,956 | 61,299 | 92,252 | |
Net working cap to sales | % | 33.9 | 33.3 | 45.0 | 52.7 | 40.2 | |
Current ratio | x | 2.0 | 2.0 | 2.4 | 2.3 | 1.7 | |
Inventory Days | Days | 84 | 76 | 85 | 95 | 82 | |
Debtors Days | Days | 116 | 90 | 120 | 128 | 129 | |
Net fixed assets | Rs m | 114,194 | 131,660 | 129,876 | 127,516 | 89,082 | |
Share capital | Rs m | 901 | 903 | 904 | 905 | 906 | |
"Free" reserves | Rs m | 110,733 | 134,073 | 134,866 | 136,517 | 124,461 | |
Net worth | Rs m | 111,634 | 134,976 | 135,771 | 137,422 | 125,367 | |
Long term debt | Rs m | 53,739 | 56,478 | 64,245 | 66,417 | 17,933 | |
Total assets | Rs m | 226,249 | 266,073 | 263,054 | 279,494 | 249,839 | |
Interest coverage | x | 56.9 | 24.2 | 10.8 | 7.1 | 5.5 | |
Debt to equity ratio | x | 0.5 | 0.4 | 0.5 | 0.5 | 0.1 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.6 | 0.5 | 0.6 | |
Return on assets | % | 10.3 | 10.2 | 1.7 | 3.3 | 0.4 | |
Return on equity | % | 20.3 | 18.9 | 1.9 | 4.4 | -2.1 | |
Return on capital | % | 20.4 | 19.3 | 3.7 | 8.8 | 8.7 | |
Exports to sales | % | 47.2 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 7.2 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 67,244 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 10,199 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 71,405 | 81,885 | 53,141 | 59,414 | 51,450 | |
Fx outflow | Rs m | 17,807 | 21,506 | 19,335 | 22,282 | 19,470 | |
Net fx | Rs m | 53,598 | 60,378 | 33,807 | 37,132 | 31,980 |
LUPIN CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -3,824 | 41,135 | 17,512 | 16,660 | 14,688 | |
From Investments | Rs m | -69,617 | -25,274 | 4,699 | -32,825 | 11,070 | |
From Financial Activity | Rs m | 58,364 | 4,332 | -14,921 | 7,441 | -8,906 | |
Net Cashflow | Rs m | -15,077 | 20,193 | 7,290 | -8,724 | 16,853 |
Share Holding
|
Company Information
|
CHM: D. B. Gupta | COMP SEC: R. V. Satam | YEAR OF INC: 1983 | BSE CODE: 500257 | FV (Rs): 2 | DIV YIELD (%): 0.6 |
Read: LUPIN 2019-20 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: WOCKHARDT SUVEN LIFE SCIENCES ORCHID PHARMA ALEMBIC PHARMA SUN PHARMA
Compare LUPIN With: WOCKHARDT SUVEN LIFE SCIENCES ORCHID PHARMA ALEMBIC PHARMA SUN PHARMA
Compare LUPIN With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 390 points, down 0.8% at 48,644 levels.
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.
For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.
Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsMy new guide will show you the huge potential in future proof businesses.
The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
More